1. Effect of Combined Bevacizumab and Temozolomide Treatment on Intramedullary Spinal Cord Tumor
   So-Jung Gwak et al, 2014, Spine CrossRef
2. Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data
   Omar Abdel-Rahman et al, 2015, Tumor Biology CrossRef
3. Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma
   KAZUHIKO KASUYA et al, 2012, Experimental and Therapeutic Medicine CrossRef
4. Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations
   Omar Abdel-Rahman, 2014, Tumor Biology CrossRef
5. Clinical Predictive Value of Serum Angiogenic Factor in Patients with Osteosarcoma
   Zhe Chen et al, 2012, Asian Pacific Journal of Cancer Prevention CrossRef
6. Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors
   Jessica E. Maxwell et al, 2016, Clinical Cancer Research CrossRef
7. Pancreatic body adenocarcinoma with neuroendocrine tumor characteristics: A case report
   HIDEHIRO TAJIMA et al, 2014, Oncology Letters CrossRef
8. An update on the management of pancreatic neuroendocrine tumors
   Limin Gao et al, 2018, Anti-Cancer Drugs CrossRef
9. Targeted therapy for gastrointestinal and pancreatic neuroendocrine tumors
   A. Z. Isyangulova et al, 2020, Malignant tumours CrossRef
10. Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study
    María Rodríguez-Remírez et al, 2020, Neuroendocrinology CrossRef